Patents by Inventor Tsang-Wu Liu

Tsang-Wu Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR IMPROVING SENSITIVITY AND SPECIFICITY OF SCREENING ASSAYS OF KRAS CODONS 12 AND 13 MUTATIONS
    Publication number: 20130217020
    Abstract: A method of diagnosing a KRAS gene mutation at codons 12-13 in a DNA sample is disclosed. The method comprises detecting one or more than one mutation in the KRAS gene codons 12-13 of the DNA sample by performing an allelic discrimination assay using a mutant probe, a wild-type probe paired with the mutant probe, a forward primer and a reverse primer, the mutant probe being adapted to detect a single nucleotide mutation at 1A, 1T, 1C, 2A, 2T, 2C or 5A of the KRAS gene codons 12-13 of the DNA sample, and the primers each having no greater than 25 nucleotides in length are adapted to amplify a region spanning KRAS exon 2 codons 12-13, wherein the mutant and wild-type probes are labeled with different fluorescent dyes.
    Type: Application
    Filed: February 22, 2012
    Publication date: August 22, 2013
    Applicant: NATIONAL HEALTH RESEARCH INSTITUTES
    Inventors: Li-Hui Chow, Tsang-Wu Liu
  • Pharmaceutical composition for the treatment of hepatocellular carcinoma
    Publication number: 20010018445
    Abstract: The invention mainly discloses a pharmaceutical composition for use in the treatment of hepatocellular carcinoma, which comprises thalidomide and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: January 24, 2001
    Publication date: August 30, 2001
    Applicant: TTY BIOPHARM COMPANY LIMITED
    Inventors: Chun-Ying Huang, Jia-Kang Whang-Peng, Li-Tzong Chen, Tsang-Wu Liu, Jang-Yang Chang, Ming-Chu Hsu